VisualAbstract: Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin | 2 Minute Medicine
Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice
Azithromycin and the Risk of Cardiovascular Death | NEJM
Safely Administering Potential QTc Prolonging Therapy Across a Large Health Care System in the COVID-19 Era | Circulation: Arrhythmia and Electrophysiology
How to Diagnose and Manage QT Prolongation in Cancer Patients | JACC: CardioOncology
Recommendations for the measurement of the QT interval during the use of drugs for COVID-19 infection treatment. Updatable in accordance with the availability of new evidence | SpringerLink
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19 - ScienceDirect
QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review - Heart Rhythm
Hydroxychloroquine-Induced QT Prolongation in a COVID-19–Positive Patient on Clozapine | Psychiatrist.com
Absence of relevant QT interval prolongation in not critically ill COVID-19 patients | Scientific Reports
Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19 - eClinicalMedicine
QT interval and repolarization dispersion changes during the administration of hydroxychloroquine/chloroquine with/without azithromycin in early COVID 19 pandemic: A prospective observational study from two academic hospitals in Indonesia - Gumilang ...
QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin | SpringerLink
The Potential for QT Interval Prolongation with Chronic Azithromycin Therapy in Adult Cystic Fibrosis Patients - Avedissian - 2019 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Wiley Online Library
Frontiers | QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection | Circulation: Arrhythmia and Electrophysiology
Ventricular Arrhythmia Risk Due to Hydroxychloroquine-Azithromycin Treatment For COVID-19 - American College of Cardiology
Myth-busting: Azithromycin does not cause torsade de pointes or increase mortality
QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019 - ScienceDirect
Comparative Pharmacodynamic Analysis of Q-T Interval Prolongation Induced by the Macrolides Clarithromycin, Roxithromycin, and Azithromycin in Rats | Antimicrobial Agents and Chemotherapy
HCQ Plus Azithromycin: A Dangerous Combination? | MedPage Today
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19 - ScienceDirect
Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine- azithromycin combination regimen - International Journal of Cardiology
Myth-busting: Azithromycin does not cause torsade de pointes or increase mortality
An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine - HeartRhythm Case Reports
Measurement and Management of QT Interval Prolongation for General Physicians | SpringerLink
